Detalhe da pesquisa
1.
Effect of Dapagliflozin Versus Placebo on Symptoms and 6-Minute Walk Distance in Patients With Heart Failure: The DETERMINE Randomized Clinical Trials.
Circulation;
149(11): 825-838, 2024 03 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38059368
2.
Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
Circulation;
2024 Apr 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38583093
3.
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
N Engl J Med;
387(12): 1089-1098, 2022 09 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36027570
4.
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial.
Eur Heart J;
45(16): 1410-1426, 2024 Apr 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38446126
5.
Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF.
Circulation;
147(22): 1670-1683, 2023 05 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37039015
6.
Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial.
Circulation;
148(22): 1735-1745, 2023 11 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37632455
7.
Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?
Circulation;
148(9): 732-749, 2023 08 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37366061
8.
Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.
Circulation;
148(24): 1945-1957, 2023 12 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37830208
9.
Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Circulation;
147(14): 1067-1078, 2023 04 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36876483
10.
Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER.
Circulation;
147(8): 624-634, 2023 02 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36342789
11.
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK.
Lancet;
401(10391): 1878-1890, 2023 06 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37156255
12.
Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
N Engl J Med;
385(25): 2325-2335, 2021 12 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34739194
13.
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.
N Engl J Med;
385(25): 2313-2324, 2021 12 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34739196
14.
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
N Engl J Med;
385(20): 1845-1855, 2021 11 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34758252
15.
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
N Engl J Med;
384(2): 105-116, 2021 01 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33185990
16.
Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study.
J Card Fail;
2024 Jan 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38215932
17.
High Risk of Stroke in Patients With Worsening Heart Failure, Reduced Ejection Fraction, Coronary Heart Disease and Sinus Rhythm: Risk Prediction Score Analysis From the COMMANDER-HF Trial.
J Card Fail;
30(4): 618-623, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38122924
18.
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF.
J Card Fail;
30(1): 26-35, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37683911
19.
Heart Failure, Investigator-Reported Sleep Apnea and Dapagliflozin: A Patient-Level Pooled Meta-Analysis of DAPA-HF and DELIVER.
J Card Fail;
30(3): 436-448, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38104937
20.
Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex.
J Gen Intern Med;
39(6): 921-930, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38097862